BioSpace News Archive

Business

CXL Ophthalmics Appoints Jonathan Talamo, MD, as Chair of the Board

CXL Ophthalmics, Inc., a clinical-stage company developing a minimally-invasive treatment for keratoconus, announced that Jonathan Talamo, MD has been appointed as its new Chair of the Board of Directors.

January 18, 2023
·
2 min read
Business

LivaNova to Announce Fourth-Quarter and Full-Year 2022 Results

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its fourth-quarter and full-year 2022 results on Wednesday, February 22, 2023 at 1 p.m. London time (8 a.m. Eastern Time).

January 18, 2023
·
2 min read
Drug Development

Anti-Cancer Potential of Rencofilstat Expanded with Results from Preclinical Multiple Myeloma Studies

Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA) today announced positive results of preclinical studies examining rencofilstat as a potential therapeutic for multiple myeloma (“MM”).

January 18, 2023
·
6 min read
Biotech Bay

FDA Clears Cytovale’s® IntelliSep® Sepsis Test, First in a New Class of Emergency Department-Focused Diagnostic Tools

Cytovale® announced today that its IntelliSep® test has received U.S. Food and Drug Administration (FDA) 510(k) clearance to aid in the early detection of sepsis for the approximately 30 million adult patients with signs and symptoms of infection who present to US emergency departments (ED) each year.

January 18, 2023
·
5 min read
Business

Virpax Pharmaceuticals to Utilize Dr. Neil K. Singla to Assist in Development of Probudur™

Virpax® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX) today announced that it will utilize leading pain expert, Dr. Neil K. Singla, to assist in the design and support of the clinical development strategy for Probudur.

January 18, 2023
·
5 min read
Pharm Country

VisualDx Awarded Grant to Advance Global Health and Diagnostic Accuracy in Underserved Regions

VisualDx, an award-winning web-based clinical decision support system, has received a grant from the Bill & Melinda Gates Foundation to develop diagnostic and surveillance tools to help medical providers improve treatment decisions and outcomes in underserved areas.

January 18, 2023
·
3 min read
OstomyCure Announces Completion of Patient Recruitment Milestone in Pivotal TIES® Clinical Trial

Pivotal clinical trial of OstomyCure’s proprietary TIES implant for people with an ileostomy

January 18, 2023
·
2 min read
New AAPS-RX Global Collaboration Produces 2-for-1 Registration Deal

AAPS to Oversee Scientific Programming for INTERPHEX Attendees of National Biotechnology Conference can register for INTERPHEX free of charge

January 18, 2023
·
4 min read
Drug Development

Monopar Announces Successful Advancement of Camsirubicin Phase 1b Clinical Trial Past Fourth Cohort, Escalates Next to 650mg/m2

Monopar Therapeutics Inc. today announced the positive recommendation from its safety review committee to advance to the fifth dose level (650 mg/m 2 ) in its camsirubicin Phase 1b trial in patients with advanced soft tissue sarcoma (ASTS).

January 18, 2023
·
5 min read
Business

KemPharm announced its partnership with Hypersomnia Foundation to Support Sleep Disorder Research and Advocacy

KemPharm, Inc. announced its partnership with the Hypersomnia Foundation , which engages, informs and champions the global community to improve the lives of people with idiopathic hypersomnia (IH) and related sleep disorders.

January 18, 2023
·
8 min read